Aurinia Pharmaceuticals Inc
NASDAQ:AUPH

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Watchlist
Price: 8.28 USD -1.19% Market Closed
Market Cap: 1.2B USD
Have any thoughts about
Aurinia Pharmaceuticals Inc?
Write Note

Aurinia Pharmaceuticals Inc
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Aurinia Pharmaceuticals Inc
Research & Development Peer Comparison

Comparables:
B
DRUG
TH
RPTX
COV
EDT

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Research & Development
-$22.9m
CAGR 3-Years
24%
CAGR 5-Years
15%
CAGR 10-Years
-13%
B
Bright Minds Biosciences Inc
CNSX:DRUG
Research & Development
-CA$5m
CAGR 3-Years
-196%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Research & Development
-$16.3m
CAGR 3-Years
15%
CAGR 5-Years
-13%
CAGR 10-Years
-11%
Repare Therapeutics Inc
NASDAQ:RPTX
Research & Development
-$131.8m
CAGR 3-Years
-50%
CAGR 5-Years
-69%
CAGR 10-Years
N/A
Covalon Technologies Ltd
XTSX:COV
Research & Development
-CA$1.5m
CAGR 3-Years
2%
CAGR 5-Years
-1%
CAGR 10-Years
-13%
Spectral Medical Inc
TSX:EDT
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Aurinia Pharmaceuticals Inc's Research & Development?
Research & Development
-22.9m USD

Based on the financial report for Sep 30, 2024, Aurinia Pharmaceuticals Inc's Research & Development amounts to -22.9m USD.

What is Aurinia Pharmaceuticals Inc's Research & Development growth rate?
Research & Development CAGR 10Y
-13%

Over the last year, the Research & Development growth was 54%. The average annual Research & Development growth rates for Aurinia Pharmaceuticals Inc have been 24% over the past three years , 15% over the past five years , and -13% over the past ten years .

Back to Top